«Paraneoplastic

Below is an extended Paraneoplastic patents listing. Click here to return to the Paraneoplastic main in depth entry.

Patents :
US Patent No.	Title
7323440	De-immunized MOG (poly)peptide constructs
7354575	Method and pharmaceutical composition for treating inflammation
7354709	Collapsin response mediator protein-1
7358355	Antibodies against human parathyroid hormone related protein
7359748	Apparatus for total immersion photography
7368527	HADDE71 polypeptides
7368531	Human secreted proteins
7371825	Anti-MCP-1 antibodies, compositions, methods and uses
7371844	Nucleic acids encoding parathyroid hormone (PTH) derivatives
7375123	1,2,4-thiadiazole derivatives as melanocortin receptor modulators
7378253	Methods of therapy and diagnosis using immunotargeting of CD84Hy1-expressing cells
7351566	27877, 18080, 14081, 32140, 50352, 16658, 14223, 16002, 50566, 65552, and 65577 molecules and uses therefor
7338781	Organic anion transporting (oat)-like protein UST3-LIKE1 and uses thereof
7335770	Triazine compounds and their analogs, compositions, and methods
7326687	CNGH0010 specific polynucleotides, polypeptides, antibodies, compositions, methods and uses
7329422	Pharmaceutical compositions
7329499	Use of a novel human ULIP6/CRMP protein in diagnosis of paraneoplastic neurological syndromes
7329529	Ubiqutin proteases
7329660	Phthalazine derivatives for treating inflammatory diseases
7332168	Composition for the elimination of autoreactive B-cells
7332488	Methods and compositions of novel triazine compounds
7332489	Methods and compositions of novel triazine compounds
7332490	Methods and compositions of novel triazine compounds
7335656	Medical devices employing triazine compounds and compositions thereof
7378492	CD40-related receptor that binds CD40L
7384908	Orally active peptides that prevent cell damage and death
7411054	25869, 25934, 26335, 50365, 21117, 38692, 46508, 16816, 16839, 49937, 49931 and 49933 molecules and uses therefor
7414028	Growth factor analogs
7414110	Human calcium channel compositions and methods
7415358	Molecular toxicology modeling
7416885	Proliferated cell lines and uses thereof
7422738	Combined cancer treatment methods using antibodies to aminophospholipids
7425334	Methods of making antibodies that bind Nogo
7426441	Methods for determining renal toxins
7427471	Modified "S" antibodies
7427590	Neurothrophic components of the ADNF I complex
7411051	Antibodies to HDPPA04 polypeptide
7410972	Compounds
7404969	Lipid nanoparticle based compositions and methods for the delivery of biologically active molecules
7384912	Treatment of bone disorders with skeletal anabolic drugs
7385036	Human tango 509 polypeptides
7390659	Methods for inducing differentiation of embryonic stem cells and uses thereof
7390820	Substituted quinolinone derivatives and methods of use
7393662	Human EPO mimetic hinge core mimetibodies, compositions, methods and uses
7393837	Inhibition of PEX in the treatment of metabolic bone diseases
7393857	Use of 5-HT.sub.3 receptor antagonists for treating musculoskeletal diseases
7393918	Protein binding miniature proteins and uses thereof
7396662	C-type lectin polypeptides
7399583	Method for the identification of inhibitors of the binding of ARE-containing mRNA and a HuR protein
7427598	Post-natal administration of activity-dependent neurotrophic factor-derived polypeptides for enhancing learning and memory

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.